Transcriptomic drug-response gene signatures are informative for the stratification of patients for clinical trials

Paul S Foster1, Jessica L Barnes1, Hock L Tay1

  • 1School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, The University of Newcastle, Callaghan, Australia; Hunter Medical Research Institute, New Lambton Heights, Australia.

Abstract

No abstract available in PubMed .